Ann I. Graul, Elisabet Cruces, Mark Stringer
Nearly 100 new drugs and biologics, including important new line extensions, were approved or launched for the first time globally in 2015. These products are covered in depth in part I of our annual review of the pharma and biotech industry.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados